Hallervorden-Spatz syndrome.
D000328:Adult; D000547:Amantadine / Q000627:therapeutic use; D001344:Autopsy; D001921:Brain / Q000378:metabolism / Q000473:pathology; D001927:Brain Diseases / Q000235:genetics*; D002540:Cerebral Cortex / Q000473:pathology; D003676:Deferoxamine / Q000627:therapeutic use; D004569:Electroencephalography; D005260:Female; D005917:Globus Pallidus / Q000473:pathology; D006801:Humans; D007501:Iron / Q000378:metabolism; D009069:Movement Disorders / Q000188:drug therapy*; D009127:Muscle Rigidity / Q000209:etiology; D006211:Pantothenate Kinase-Associated Neurodegeneration / Q000150:complications / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D011011:Pneumoencephalography; D013378:Substantia Nigra / Q000473:pathology
D000547:Amantadine; D007501:Iron; D003676:Deferoxamine